Subscribe to Seeking Alpha feed
https://seekingalpha.com
URL: https://seekingalpha.com
Updated: 33 min 10 sec ago

Cloudflare: Growth Will Disappoint Long Term

Thu, 10/23/2025 - 18:20

Navitas: Time To Take Profits As Two Downside Catalysts Loom

Thu, 10/23/2025 - 18:16

ITOCHU Corporation (ITOCY) Discusses Establishment and Role of CXO in Integrating Management Strategy with Digital Technologies - Slideshow

Thu, 10/23/2025 - 18:09

Globe Life outlines 17% EPS growth and targets $1.4B annual sales by 2030 as technology boosts agent productivity

Thu, 10/23/2025 - 18:08

Elutia Inc. (ELUT) Presents at LD Micro Main Event XIX Investor Conference - Slideshow

Thu, 10/23/2025 - 18:07

Lumos Diagnostics Holdings Limited (LDXHF) Shareholder/Analyst Call - Slideshow

Thu, 10/23/2025 - 18:06

Atea ASA 2025 Q3 - Results - Earnings Call Presentation

Thu, 10/23/2025 - 18:05

ORIX JREIT Inc. 2025 Q4 - Results - Earnings Call Presentation

Thu, 10/23/2025 - 18:04

Wipro Limited 2026 Q2 - Results - Earnings Call Presentation

Thu, 10/23/2025 - 18:04

ABB Ltd 2025 Q3 - Results - Earnings Call Presentation

Thu, 10/23/2025 - 18:03

Grupo Industrial Saltillo, S.A.B. de C.V. 2025 Q3 - Results - Earnings Call Presentation

Thu, 10/23/2025 - 18:01

Autoliv, Inc. 2025 Q3 - Results - Earnings Call Presentation

Thu, 10/23/2025 - 18:01

Xvivo Perfusion AB (publ) 2025 Q3 - Results - Earnings Call Presentation

Thu, 10/23/2025 - 17:58

Valero says moving ahead to shut California refinery after talks with officials

Thu, 10/23/2025 - 17:53

Knowles expects high end of 4%–6% organic growth range for 2026 while ramping specialty film capacity

Thu, 10/23/2025 - 17:48

Amphenol: Another Great Quarter, But Shares Are Overvalued

Thu, 10/23/2025 - 17:42

Intel Q3 2025 Earnings Double Beat: The Devil Is In The Details (Downgrade)

Thu, 10/23/2025 - 17:41

South Plains Financial targets up to 20% lending platform growth while expanding M&A discussions

Thu, 10/23/2025 - 17:38

Associated Banc-Corp targets 5%–6% annual loan growth amid record net interest income and strong C&I momentum

Thu, 10/23/2025 - 17:38

Ventyx Biosciences, Inc. (VTYX) Discusses Positive Phase II Results of VTX3232 in Obesity and Cardiovascular Risk Factors - Slideshow

Thu, 10/23/2025 - 17:38

Pages